PRIVA-DULOXETINE

nora pharma inc🇨🇦 Health Canada

Approval Id: bdaa4114f435d5e0
Drug Approval Canada Name: PRIVA-DULOXETINE
Product Name: PRIVA-DULOXETINE
Status: Cancelled Post Market
Status Date: 2023-01-01
Original Market Date: 2020-05-07
Din: 02490420
Drug Class: Human
Dosage Form: Capsule (Delayed Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.16
Atc Original: N06AX21 DULOXETINE
Atc Name: n 06 ax 21
Aig Number: 0152350002
Company Name: nora pharma inc
Company Address: 1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7

DULOXETINE (DULOXETINE HYDROCHLORIDE)

60 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bdaa4114f435d5e0

Type

Standard